Entries by Vivek Sharavanan

Opportunities Exist in the Post-Pandemic Landscape of Genomics and DNA Sequencing

In 2020, when the world was grappling with the onset of the COVID-19 pandemic, next-generation sequencing (NGS) companies became instrumental in developing comprehensive testing and research strategies to fight the virus. Some sequencing companies have expanded their offerings to include COVID-19 testing kits, vaccines, therapeutics, and other related products. Notably, Illumina, a global leader in […]